F-star Therapeutics, Inc. EBITDA Margin 2016-2022 | FSTX
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for F-star Therapeutics, Inc. (FSTX) over the last 10 years. The current EBITDA margin for F-star Therapeutics, Inc. as of September 30, 2022 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2022-09-30 | $0.02B | $-0.04B | -171.43% |
| 2021-12-31 | $0.02B | $-0.03B | -142.86% |
| 2021-09-30 | $0.00B | $-0.04B | -1075.00% |
| 2021-03-31 | $0.01B | $-0.03B | -207.69% |
| 2020-12-31 | $0.01B | $-0.02B | -200.00% |
| 2016-06-30 | $0.00B | $-0.02B | inf% |
| 2016-03-31 | $0.00B | $-0.02B | inf% |
| 2015-12-31 | $0.00B | $-0.01B | inf% |
